Diabetes due to Risperdal

CALL AND GET HELP NOW (888) 485-5226

Risperdal and Diabetes

One of the unintended side effects of taking the antipsychotic drug Risperdal is that it has a tendency to cause excessive weight gain, which is likely to increase a person’s risk of developing type 2 diabetes. Diabetes is a metabolic condition where the body develops a resistance to insulin, which is a hormone that helps regulate the rate at which cells absorb sugar from the blood. When the cells become resistant to insulin, there is an increase of sugar levels in the blood, which can trigger hyperglycemia. Diabetes is a lifelong condition that requires constant monitoring and management.

Link Between Risperdal and Diabetes

A 2006 study published in the American Journal of Epidemiology found a link between taking Risperdal and the risk of developing type 2 diabetes. A third of those subjects taking Risperdal who were being treated for psychiatric disorders during the studied developed type 2 diabetes. This data is similar to the results found in a 2003 study published in Pharmacotherapy. In the 2003 study, type 2 diabetes, also referred to as diabetes mellitus, was found to be associated with taking Risperdal.

A 2013 study published in JAMA Psychiatry, indicated a link between the use of antipsychotic drugs in children and an increased risk of developing type 2 diabetes. The study found that children taking antipsychotics were up to three times more likely to develop diabetes. When looking specifically at the data for Risperdal, children were 2.2 times more likely to develop type 2 diabetes compared to children who were not treated with Risperdal.

The FDA Requires Diabetes Warning for Risperdal

In 2003, the FDA required that all antipsychotic drugs, like Risperdal, include a warning label on the drug packaging that advises users of the known correlation between the use of antipsychotic drugs and an increased risk of developing type 2 diabetes. While Janssen obliged the product labeling requirement set forth by the FDA, Janssen also sent out a letter to health care providers that the FDA considered to be false and misleading for including statements such as “Risperdal is not associated with an increased risk of diabetes when compared to untreated patients, or patients treated with conventional antipsychotics.” The FDA indicated that the statement suggested that Risperdal does not increase the risk of diabetes, which is the exact opposite of what the warning indicates. The FDA demanded that Janssen cease sending out letters like these to health care providers.

Sadly, far too many will be injured by Risperdal side effects. However, those who suffer damages can file a Risperdal lawsuit with the assistance of an experienced Risperdal attorney. Don’t hesitate to contact a lawyer today who can help you file a claim within the statute of limitations to ensure you are eligible for compensation.

Request a FREE Consulation